The purpose of this core is to pursue and support the investigation of sex- specific factors in nicotine-dependence and treatment. The function of the core is supported by an emerging empirical literature, and by national research goals. The core will support all Center investigators, and it will be linked to other institutional programs at Yale in order to enhance transdisciplinary collaboration. Although the core will initiated independent projects, its primary mission will be cost-effective attention to sex-specific factors in current and new projects through such means as pooling data to test sex-related hypothesis, including assessments related to sex and gender issues, ensuring adequate representation of women so that sex related comparisons can be made, and taking charge of data analysis and interpretation of findings pertaining to sex differences for all appropriate Center projects. Improvement in the health of women and men depends upon new-found scientific knowledge which recognizes sex-specific effects. The core is directed toward strengthening existing research in nicotine dependence as it relates to sex and gender, and developing new, cutting-edge areas of investigation that will result in direct practical benefit.
The specific aims of the core are as follows; 1) Testing sex-specific models of smoking maintenance 2) Assessing sex-specific benefits of smoking cessation. 3) Investigating the relationship of sex-specific hormonal factors to treatment response and relapse. 4) Providing support and methodological consultation to investigators examining sex and gender effects in Center projects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
1P50DA013334-01
Application #
6261959
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (O1))
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Geha, Paul; Cecchi, Guillermo; Todd Constable, R et al. (2017) Reorganization of brain connectivity in obesity. Hum Brain Mapp 38:1403-1420
Roberts, Walter; Verplaetse, Terril L; Moore, Kelly et al. (2017) Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms. J Psychopharmacol 31:906-914
Corbin, William R; Papova, Anna; Morean, Meghan E et al. (2015) Integrating acquired preparedness and dual process models of risk for heavy drinking and related problems. Psychol Addict Behav 29:864-74
Smith, Megan V; Ramsay, Christina; Mazure, Carolyn M (2014) Understanding disparities in subpopulations of women who smoke. Curr Addict Rep 1:69-74
Avery, Naomi; Kenny, Anne M; Kleppinger, Alison et al. (2014) Effects of varenicline, nicotine or placebo on depressive symptoms in postmenopausal smokers. Am J Addict 23:459-65
Morean, Meghan E; DeMartini, Kelly S; Leeman, Robert F et al. (2014) Psychometrically improved, abbreviated versions of three classic measures of impulsivity and self-control. Psychol Assess 26:1003-20
King, Andrea C; Cao, Dingcai; Zhang, Lingjiao et al. (2013) Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial. Biol Psychiatry 73:924-30
Duncan, Lindsay R; Latimer, Amy E; Pomery, Elizabeth et al. (2013) Testing messages to encourage discussion of clinical trials among cancer survivors and their physicians: examining monitoring style and message detail. J Cancer Educ 28:119-26
Geha, Paul Y; Aschenbrenner, Katja; Felsted, Jennifer et al. (2013) Altered hypothalamic response to food in smokers. Am J Clin Nutr 97:15-22
Cosgrove, Kelly P; Esterlis, Irina; McKee, Sherry A et al. (2012) Sex differences in availability of ?2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry 69:418-27

Showing the most recent 10 out of 96 publications